| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |